| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/08/2007 | US20070053980 Extended release tiagabine formulations with reduced side-effects |
| 03/08/2007 | US20070053964 Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist |
| 03/08/2007 | US20070053943 Dimethicone-containing sustained release injection formulation |
| 03/08/2007 | US20070053942 Disinfectant and/or bactericidal aqueous compositions |
| 03/08/2007 | US20070053939 Biguanide drug-containing jelly preparation |
| 03/08/2007 | US20070053929 Marine algae extract and lipase inhibitor containing the same |
| 03/08/2007 | US20070053906 Liquid formulations of tumor necrosis factor-binding proteins |
| 03/08/2007 | US20070053900 High concentration antibody and protein formulations |
| 03/08/2007 | US20070053839 Directing cells to target tissues organs |
| 03/08/2007 | US20070053836 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 03/08/2007 | US20070053835 Antibodies (monoclonal, humanized) conjugated to antigrowth/cytotoxic agents (maytansinoids, calicheamicins); host cells |
| 03/08/2007 | DE19619837B4 Kosmetische oder pharmazeutische Zubereitungen mit vermindertem Klebrigkeitsgefühl Cosmetic or pharmaceutical preparations with reduced stickiness |
| 03/08/2007 | DE10331253B4 Therapeutika gegen Parasiten von Fischen Therapeutics against parasites of fish |
| 03/08/2007 | DE102005005573B4 Hydrophiles Gelsystem zur Hautpflege auf Basis von Karaya-Gummi Hydrophilic gel system for skin care on the basis of karaya gum |
| 03/08/2007 | DE10161149B4 Verwendung von Heparin-haltigem Ophthalmikum Use of heparin-containing ophthalmic |
| 03/08/2007 | CA2848021A1 Compostions and methods for preparation of poorly water soluble drugs with increased stability |
| 03/08/2007 | CA2625951A1 Anti-apoptotic protein antibodies |
| 03/08/2007 | CA2621786A1 Polysaccharide microparticles containing biological agents: there preparation and applications |
| 03/08/2007 | CA2621377A1 Antitumor agent |
| 03/08/2007 | CA2621200A1 Transdermal active principle delivery means |
| 03/08/2007 | CA2621037A1 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| 03/08/2007 | CA2620687A1 Composition for diet comprising plant essential oil as active ingredient,sheet type composition for diet comprising thereof, percutaneous pharmaceutical agent for diet comprising thereof, and method for producing thereof |
| 03/08/2007 | CA2620638A1 Liquid formulations of pegylated growth hormone |
| 03/08/2007 | CA2620585A1 Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents |
| 03/08/2007 | CA2620429A1 Anti-inflammatory compositions and methods of use |
| 03/08/2007 | CA2620389A1 Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| 03/08/2007 | CA2619460A1 Method of removing medical adhesive |
| 03/08/2007 | CA2617920A1 Argatroban formulation comprising an acid as solubilizer |
| 03/08/2007 | CA2616470A1 Chitosan-silicon dioxide coprecipitate and use as excipient in solid dosage forms |
| 03/07/2007 | EP1760155A2 Non-human sperm-DNA complexes for geneticallly modifying non-human animals |
| 03/07/2007 | EP1759713A2 Lock and key micelles |
| 03/07/2007 | EP1759712A2 Rapidly disintegrable pharmaceutical composition |
| 03/07/2007 | EP1759711A1 Chitosan-silicon dioxide coprecipitate and use as excipient in solid dosage forms |
| 03/07/2007 | EP1759699A1 Liposome preparation containing slightly water-soluble camptothecin |
| 03/07/2007 | EP1759007A2 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 03/07/2007 | EP1759001A1 Bone delivery conjugates and method of using same to target proteins to bone |
| 03/07/2007 | EP1758621A1 Bioactive biomaterials for controlled delivery of active principles |
| 03/07/2007 | EP1758613A2 Compositions and methods for modulating bone mass |
| 03/07/2007 | EP1758612A2 Composition comprising intercalated functional-active organic compounds |
| 03/07/2007 | EP1758608A2 Conjugates of hydroxyethyl starch and erythropoietin |
| 03/07/2007 | EP1758604A2 Method for improved breast milk feeding to reduce the risk of allergy |
| 03/07/2007 | EP1758595A2 Use of lipid conjugates in the treatment of diseases |
| 03/07/2007 | EP1758591A1 Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology |
| 03/07/2007 | EP1758589A1 Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof |
| 03/07/2007 | EP1758586A1 Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase |
| 03/07/2007 | EP1758559A1 Process for the selective increase of a release rate of an active material from a pharmaceutical composition |
| 03/07/2007 | EP1758555A1 Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel |
| 03/07/2007 | EP1758553A1 Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons |
| 03/07/2007 | EP1758532A2 Topical preparation and method for transdermal delivery and localization of therapeutic agents |
| 03/07/2007 | EP1758464A2 Nutritional food and feed, composition, processing and method of use |
| 03/07/2007 | EP1758458A2 Compositions containing opioid antagonists |
| 03/07/2007 | EP1521574B1 Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof |
| 03/07/2007 | EP1465600B1 Particulate compositions comprising a lipophilic liquid |
| 03/07/2007 | EP1462101B1 Drinkable preparation comprising ketoprofen and use thereof in the simultaneous treatment of a group of animals of respiratory diseases |
| 03/07/2007 | EP1457212B1 Eye drops |
| 03/07/2007 | EP1406591B1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 03/07/2007 | EP1352061B9 Method for inhibiting the expression of a target gene |
| 03/07/2007 | EP1351704B1 Storage stable powder compositions of interleukin-4 receptor |
| 03/07/2007 | EP1327149A4 Methods of high-throughput screening for internalizing antibodies |
| 03/07/2007 | EP1313449B1 Amphotericin b structured emulsion |
| 03/07/2007 | EP1307232B1 Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| 03/07/2007 | EP1261622B1 Purified recombinant hlh having a specific bioactivity and process for purification thereof |
| 03/07/2007 | EP1257695B1 Biomolecules having multiple attachment moieties for binding to a substrate surface |
| 03/07/2007 | EP1255544B1 Mucin synthesis inhibitors |
| 03/07/2007 | EP1248596B1 Implantation kit comprising a support phase and a solvent |
| 03/07/2007 | EP1105098B1 Liposomal therapeutic compositions obtainable through the use of an ammonium sulphate gradient |
| 03/07/2007 | EP1100549B1 A novel excipient for the lyophilization of aqueous suspensions of microparticles |
| 03/07/2007 | EP1044013B1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers |
| 03/07/2007 | EP1028753B2 Delivery of poly (ethylene glycol) -conjugated molecules from degradable hydrogels |
| 03/07/2007 | EP0838221B1 Lyophilized hgf preparations |
| 03/07/2007 | EP0585242B2 Wound healing |
| 03/07/2007 | CN1926155A 羟乙基淀粉 Hydroxyethyl starch |
| 03/07/2007 | CN1925876A Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy |
| 03/07/2007 | CN1925875A Chemically modified small molecules |
| 03/07/2007 | CN1925874A Compositions and methods of delivery of pharmacological agents |
| 03/07/2007 | CN1925873A Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| 03/07/2007 | CN1925871A Polymer-bound antibody concer therapeutic agent |
| 03/07/2007 | CN1925868A Paraoxonase-containing pharmaceutical preparation |
| 03/07/2007 | CN1925867A Pharmaceutical formulations for the sustained release of interleukins and therapeutic applications thereof |
| 03/07/2007 | CN1925861A Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 03/07/2007 | CN1925845A Powdered compositions of sensitive active materials in an at least partially amorphous state |
| 03/07/2007 | CN1925843A Methods and compositions for the production of monoclonal antibodies |
| 03/07/2007 | CN1925841A Pharmaceutical preparation for the oral cavity |
| 03/07/2007 | CN1923289A Hybrid yeast avian influenza vaccine |
| 03/07/2007 | CN1923288A Hybrid yeast influenza vaccine |
| 03/07/2007 | CN1923287A Drug loaded magnetic chirality chitose nano particle |
| 03/07/2007 | CN1923251A Complex traditional Chinese medicine preparation for treating acute and chronic urinary tract infection and preparing method thereof |
| 03/07/2007 | CN1923204A Medicine composition of rimonabant or medicinal salt thereof, and its preparation and use |
| 03/07/2007 | CN1923181A Valsartan drops and its preparation method |
| 03/07/2007 | CN1923178A Oleanolic acid liposome preparation, freeze dried powder injecta thereof and its preparation |
| 03/07/2007 | CN1923175A Slow release injection comprising anticancer antibiotics and booster thereof |
| 03/07/2007 | CN1923174A Anti-cancer slow release injection comprising anticancer antibiotics |
| 03/07/2007 | CN1923173A Anti-cancer drugs slow release agent comprising anticancer antibiotics and booster thereof |
| 03/07/2007 | CN1923172A Drug slow release agent comprising anticancer antibiotics and booster thereof |
| 03/07/2007 | CN1923171A Compound recipe anti-cancer drugs slow release agent comprising anticancer antibiotics and booster thereof |
| 03/07/2007 | CN1923170A Imiquimod turbid liquor and gelling agent thereof |
| 03/07/2007 | CN1923168A External use plaster for treating acute jerk contused wound |
| 03/07/2007 | CN1303107C Crystalline mixtures of partial methyl ethers of beta cyclodextrin and related compounds |
| 03/07/2007 | CN1302813C Transmission system for medicine containing trehalose and hyaluronic acid in use for curing burn and preparing method |
| 03/07/2007 | CN1302812C Transmission system of medicine containing trehalose and hyaluronic acid for eye part and its preparation method |